Official UK procurement notice
Primary human cells for Organ-on-chip studies
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionPurchase HLA typed human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L) and human immune cells (PMBC). Cells will be used in an established Organ on a Chip (OOC) system at Porton Down.
CPV: Primary cells
The lotProcurement structure
single lot · no lot value publishedLot #1This project requests funding to purchase HLA typed human small airway epithelial…Awarded
This project requests funding to purchase HLA typed human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L) and human immune cells (PMBC). Cells will be used in an established Organ on a Chip (OOC) system at Porton Down.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 13 Sept 2024, 16:08 BST
- Last source update
- 13 Sept 2024, 16:08 BST
- Authority reference
C284246- FTS notice number
2024/S 000-029468- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-049aeeFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The absence of competition ground under Regulation 32(2)(b)(ii) is relevant as, based upon UKHSA’s requirements and market intelligence, there appears to be a monopoly market that applies in the current case. Operational colleagues have confirmed that there is a very limited market for the supply of cells from recently deceased, healthy humans appropriate for UKHSA’s income generation and infectious disease research purposes.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lonza Sales Ltd | £226,707 † | — | Awarded |
Contracts
Contract 029468-2024-1 · Lonza Sales Ltd
- Signed
- 4 Jul 2024
- Value
- £226,707
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Commercial CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Lonza Sales LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.